ArticleTobacco induced diseases2025
Self-reported dyspnea and interest in a respiratory muscle training program among callers to the New York State Quitline.
Article in Tobacco induced diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionCigarette smoking is an important risk factor in the development of dyspnea. Programs designed to strengthen the respiratory muscles can improve dyspnea in people with or without lung disease. As a first step in understanding the feasibility of offering a respiratory muscle training (RMT) program to people who are seeking help to try to quit smoking, we asked callers who contacted the New York State Quitline about their dyspnea and potential interest in a home-based RMT program.
methodsConsecutive callers who contacted the New York State Quitline (n=1019) between 19 May and 9 June 2023 completed the Modified Medical Research Council (mMRC) dyspnea scale and reported their level of interest in RMT. Participants were categorized as: high breathlessness (HB: 0-1), or low breathlessness (LB: 2-4). We examined characteristic differences between participants who reported HB versus LB and examined differences in level of interest in home-based RMT.
resultsThose with HB were older [mean (SD): 61.3 (12.5) vs 53.6 (15.0) years, p<0.001], had more cumulative years of smoking [38.8 (15.1) vs 28.8 (15.4) years, p<0.001], smoked more cigarettes per day [19.3 (10.5) vs 17.3 (8.8), p<0.01], reported more disability (p<0.001) and chronic health conditions (78.5% vs 53.9%, p<0.001). Those with HB also expressed greater interest in RMT [7.8 (3.3) vs 6.2 (4.1), p<0.001].
conclusionsThese preliminary findings suggest that about 20% of quitline callers report clinically significant levels of breathlessness and most respondents, regardless of their level of breathlessness, report interest in a home-based RMT program, underscoring a potential opportunity to offer this program along with cessation support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.